TMCnet News
Willow Biosciences Inc. to Webcast Live at Life Sciences Investor Forum September 16thVANCOUVER, British Columbia, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Willow Biosciences Inc. (TSX: WLLW, OTCQX: CANSF), based in Vancouver, Canada and is a leading biotechnology company that manufactures ultra-pure, sustainably produced cannabinoids via yeast-based biosynthesis, today announced that Trevor Peters, President & Chief Executive Officer, will present live at LifeSciencesInvestorForum.com on September 16th. DATE: Thursday, September 16th It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. Learn more about the event at www.lifesciencesinvestorforum.com. Recent Company Highlights
About Willow Biosciences Inc. Willow is a leading biotechnology company based in that develops and produces high-purity, plant derived ingredients for the consumer care, food and beverage, and pharmaceutical markets. Willow's biotechnology platform allows creation of a consistent, scalable and sustainable product that benefits both B2B and B2C customers. Willow's R&D team has a proven track record of developing and commercializing bio-based manufacturing processes and products for both the consumer and pharmaceutical industries. About Life Sciences Investor Forum A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network. CONTACTS: Willow Biosciences Inc. Troy Talkkari Vice President, Corporate Development 403.618.1117 [email protected] Life Sciences Investor Forum John M. Viglotti SVP Corporate Services, Investor Access (212) 220-2221 [email protected] |